Send to

Choose Destination
Clin Cancer Res. 2016 Oct 15;22(20):5152-5158. Epub 2016 May 11.

IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.

Author information

Service des maladies du sang, Hôpital Huriez, CHRU, Lille France.
DBIM, Hôpital Saint Louis, AP-HP, Paris, France.
Service d'Hématologie et Thérapie cellulaire, Hopital La Milétrie, CHU Poitiers, France. Inserm CIC U1402.
Service de biochimie spécialisée des protéines, CHRU, Lille France.
Hématologie, IUCT Oncopole Toulouse, France.
Service d'Hématologie, Hôpital La Pitie Salpêtrière, AP-HP, Paris, France.
Department of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom. The Binding Site Ltd, Birmingham, United Kingdom.
Service d'Hématologie et Thérapie cellulaire, Hopital La Milétrie, CHU Poitiers, France. Inserm CIC U1402.



Accurate quantification of monoclonal IgM immunoglobulins is essential for response assessment in patients with Waldenström's macroglobulinaemia (WM). The propensity of IgM to form multimers in serum makes sample evaluation by current laboratory methods particularly challenging.


We assessed the precision and linearity of IgMκ and IgMλ heavy/light chain (HLC, Hevylite) assays, and established reference intervals using 120 normal donor sera. We compared the quantitative performance of HLC assays with serum protein electrophoresis (SPE) and total IgM nephelometry for 78 diagnostic samples and follow-up samples from 25 patients with WM. Comparisons were made between the three methods for diagnostic sensitivity and response assessment.


IgMκ and IgMλ HLC assays showed low imprecision and good linearity. There was good agreement between summated HLC (IgMκ + IgMλ) and total IgM (measured nephelometrically; R2 = 0.90), but only moderate agreement between involved IgM HLC and SPE densitometry (R2 = 0.49). Analysis of 120 normal donor sera produced the following normal ranges: IgMκ: 0.29-1.82 g/L; IgMλ: 0.17-0.94 g/L; IgMκ/IgMλ ratio: 0.96-2.30. Using these ranges, IgM HLC ratios were abnormal in all WM presentation sera tested, including 15 with non-quantifiable SPE. Despite discordance in quantitation, responses assigned with HLC assays showed excellent agreement to those based on international guidelines using SPE or total IgM; although abnormal HLC ratios indicated residual disease in some patients with negative electrophoresis results.


Nephelometric assessment of IgMκ and IgMλ HLC pairs offers a quantitative alternative to traditional laboratory techniques for the measurement of monoclonal IgM and may aid in the management of WM. Clin Cancer Res; 22(20); 5152-8. ©2016 AACR.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center